Your browser is out-of-date.

Please, update your browser to view this website correctly. Update my browser now

×

36th Vicenza Course on AKI &CRRT

Room: AKI Path | Room Tiziano

SESSION 2 | New mechanisms in AKI (Joint UVA | IRRIV session)

Chairmen: 

G. Kinsey | F. Ferrari

08.10

Acute, Severe Hyponatremia in the ICU

 

M. Rosner

08.30

Regulatory T Cells in AKI

 

G. Kinsey 

08.50

New and Emerging Nephrotoxins

 

J. King

09.10

Extracellular vesicles in AKI and repair

 

U. Erdbrügger

09.30

Discussion

 

09.40

Break

 

SESSION 3 | Major CCN papers of 2016 | 2017

Chairmen: 

A. Pani | R. Bellomo

 

10.00

PRESERVE trial

 

P. Palevsky

10.15

SMART and SALT-ED trial

 

A. Shaw

10.35

DoReMiFa

 

M. Ostermann

10.45

AKI and Angiotensin II

 

R. Bellomo

11.00

The AM Pharma trial results

 

J. Kellum

11.20

Discussion

 

11.30 Industry-Sponsored Symposium 1

13.00 LUNCH

13.30 Industry-Sponsored Symposium 2

SESSION 4 | Prevention and Recovery (Joint ADQI | IRRIV session)

Chairmen: 

L. Gesualdo | T.B.A.

 

15.00

Patterns of renal recovery after AKI

 

J. Kellum

15.20

Renal Functional Reserve before and after AKI

 

F. Husain-Syed

15.40

CT Surgery (ADQI 20)

 

A. Shaw

16.00

ECOS and Artificial Organ Interaction

 

C. Ronco

16.20

Discussion

 

16.30

Break

 

SESSION 5 | New technologies

Chairmen: 

K. Kashani | T. Rimmelé

17.00

Real time GFR

 

A. Shaw

17.20

 Electronic Decision support

 

K. Kashani

17.40

KDIGO-Bundles and NRRT for AKI

 

A. Zarbock

18.00

NINJA (Drug|associated AKI)

 

S. Goldstein

18.20

Discussion

 

18.30

Break

 

Room: CRRT Path | Room Giotto

SESSION 2 | Clinical aspects of CRRT

Chairmen: 

M. Ostermann | V. Cantaluppi

08.10

Clinical Indications for CRRT

 

R.L. Mehta

08.30

Timing of initiation of CRRT

 

S. Bagshaw

08.50

How to prescribe CRRT

 

C. Ronco

09.10

Choice of CRRT Modality

 

R. Bellomo

09.30

Discussion

 

09.40

Break

 

SESSION 3 | Practical Management of CRRT

Chairmen: 

I. Baldwin | S. Romagnoli

10.00

TIMING of RRT trials: where are we now?

 

S. Bagshaw

10.20

Acid Base and Electrolyte correction| 

 

Q. Qian

10.40

Managing nutrition in CRRT patients

 

P. Honoré

11.00

CRRT Discontinuation: When and how?

 

S. Bagshaw

11.20

Discussion

 

11.30 Industry-Sponsored Symposium 1

13.00 LUNCH

13.30 Industry-Sponsored Symposium 2

SESSION 4 | Pediatric AKI (Joint CCH | IRRIV session)

Chairmen: 

S. Goldstein | L. Murer 

15.00

Pediatric AKI: Epidemiology and Outcomes

 

S. Sutherland

15.20

AKI in Neonates: Epidemiology and Outcomes

 

D.J. Askenazi

15.40

Acute RRT in the Pediatric Setting

 

Z. Ricci

16.00

Moving Forward with AKI Treatment in Children: Risk Stratification and Biomarker Integration to Direct Care

S. Goldstein

16.20

Discussion

16.30

Break

 

SESSION 5 | Precision medicine in AKI and sepsis (Joint CCCN | IRRIV)

Chairmen: 

R. Murugan | G. Villa

17.00

Precision medicine and Critical Care Nephrology

J. Kellum

17.20

Tolerance: a host-specific protective mechanism in sepsis induced AKI?                                      

 

H. Gomez Danies

17.40

Precision medicine and CRRT

 

P. Palevsky

18.00

Precision fluid balance: The role of net UF intensity

 

R. Murugan

18.20

Discussion

 

18.30

Adjourn